dose-intens meta-analysi chemotherapi regimen small-cel carcinoma lung chemotherapi intens DI treatment outcom studi limited- extensive-stag small-cel carcinoma lung sccl relationship DI respons complet respons CR partial respons PR median surviv MS agent regimen cyclophosphamid cisplatin rel DI rdi studi regimen refer regimen regress analysi analysi individu drug rdi combin cav rdi regimen correl outcom individu drug rdi rdi attain CR limit diseas unduli influenti observ extensive-stag diseas rdi cr+ PR random trial correl statist signific unduli influenti observ cae cave rdi regimen MS extensive-stag diseas rdi limit diseas rdi EP signific correl di-outcom correl consist chemotherapi sccl meta-analysi retrospect data hypothes prospect clinic trial studi sampl method analysi conclus 